Institute of Biomedical Engineering, École Polytechnique, Montreal, QC, H3T 1J4, Canada.
Department of Chemical Engineering, École Polytechnique, Montreal, QC, H3T 1J4, Canada.
Biomaterials. 2017 Jun;129:127-138. doi: 10.1016/j.biomaterials.2017.03.022. Epub 2017 Mar 15.
Chitosan is a family of glucosamine and N-acetyl glucosamine polysaccharides with poorly understood immune modulating properties. Here, functional U937 macrophage responses were analyzed in response to a novel library of twenty chitosans with controlled degree of deacetylation (DDA, 60-98%), molecular weight (1 to >100 kDa), and acetylation pattern (block vs. random). Specific chitosan preparations (10 or 190 kDa 80% block DDA and 3, 5, or 10 kDa 98% DDA) either induced macrophages to release CXCL10 and IL-1ra at 5-50 μg/mL, or activated the inflammasome to release IL-1β and PGE at 50-150 μg/mL. Chitosan induction of these factors required lysosomal acidification. CXCL10 production was preceded by lysosomal rupture as shown by time-dependent co-localization of galectin-3 and chitosan and slowed autophagy flux, and specifically depended on IFN-β paracrine activity and STAT-2 activation that could be suppressed by PGE. Chitosan induced a type I IFN paracrine response or inflammasome response depending on the extent of lysosomal rupture and cytosolic foreign body invasion. This study identifies the structural motifs that lead to chitosan-driven cytokine responses in macrophages and indicates that lysosomal rupture is a key mechanism that determines the endogenous release of either IL-1ra or IL-1β.
壳聚糖是一种带有氨基葡萄糖和 N-乙酰氨基葡萄糖的多糖,其免疫调节特性尚不清楚。在这里,分析了功能化 U937 巨噬细胞对 20 种壳聚糖的新型文库的反应,这些壳聚糖的脱乙酰度(DDA,60-98%)、分子量(1 至> 100 kDa)和乙酰化模式(块状与随机)具有可控性。特定的壳聚糖制剂(10 或 190 kDa 80%DDA 和 3、5 或 10 kDa 98%DDA)要么以 5-50μg/mL 的浓度诱导巨噬细胞释放 CXCL10 和 IL-1ra,要么以 50-150μg/mL 的浓度激活炎症小体释放 IL-1β 和 PGE。壳聚糖诱导这些因子的释放需要溶酶体酸化。溶酶体破裂导致了 CXCL10 的产生,这表现为半乳糖凝集素-3 和壳聚糖的时间依赖性共定位,以及自噬流的减缓,并且特别依赖于 IFN-β 旁分泌活性和 STAT-2 激活,这可以通过 PGE 来抑制。壳聚糖诱导 I 型 IFN 旁分泌反应或炎症小体反应,具体取决于溶酶体破裂和细胞质异物入侵的程度。本研究确定了导致巨噬细胞中壳聚糖驱动细胞因子反应的结构基序,并表明溶酶体破裂是决定内源性释放 IL-1ra 或 IL-1β 的关键机制。